Shares of Sun Pharmaceutical Industries Ltd. 524715 advanced 1.16% to 1,806.90 Indian rupees Thursday, on what proved to be ...

Novo Nordisk Sun Pharma The approval marks a major win for Sun Pharma in its patent dispute with Danish drugmaker Novo Nordisk, the company that manufactures weight loss drug Ozempic ...

Sun Pharmaceutical Industries Ltd. closed 6.06% short of its 52-week high of 1,910.00 rupees, which the company achieved on ...

The court, however, permitted Sun Pharma to manufacture and export semaglutide to non-patent countries, extending the same relief it granted Dr. Reddy’s Laboratories in a similar dispute earlier this ...

Sun Pharmaceutical Industries Limited ( ($IN:SUNPHARMA) ) just unveiled an announcement. Sun Pharmaceutical Industries Limited announced that its ...

The dispute centres on Novo Nordisk's Indian patents for semaglutide, which it markets globally as Ozempic and Wegovy for ...

Sun Pharmaceutical Industries on Monday said it has launched its global innovative drug ILUMYA in India for the treatment of ...

A unit of Sun Pharmaceutical Industries plans to invest Rs 3,000 crore on a new manufacturing plant in Madhya Pradesh, according to a regulatory filing.

Sun Pharma's managing director, Kirti Ganorkar, said Ilumya is already available in 35 countries and has consistently ...

Sun Pharma concludes National B-school Competition SUN PRISM 2025: Our Bureau, Mumbai Thursday, December 11, 2025, 16:30 Hrs [IST] Sun Pharmaceutical Industries Limited, India’s ...

Sun Pharmaceutical Industries has announced the launch of its global innovative drug, Ilumya (tildrakizumab) in India for ...